The chancellor has given the NHS some remission, but he is a long way from providing a cure.
Given the probability of remission was p=0.30 for treatment A and p=0.45 for treatment B, then for equal N in each group, α =.05 and (1-β) = 0.80, the required sample size is N =180 (each group; calculated with PASS2008).
A total of 323 GMA sessions were given to the remission patients upon relapse and a total of 566 months in remission was achieved, equivalent to 1.75 months per apheresis column for patients in remission, which reflects a cost of 1150 $/remission month.
Given the durable complete cytogenetic remission rates, as expected, the estimated event-free survival at 24 months was 90% and the transformation-free survival rate was 98%.
Nevertheless, given the significant correlation between remission rate and renal survival, it can be expected that tip variant may have favorable long-term outcome.
Although data from the STORI trial 18 suggested that infliximab withdrawal was successful in approximately half of patients with CD in stable remission, given the progressive and lifelong nature of CD, physicians should carefully consider the risks and benefits of different approaches in the long-term use of biologics.
Given the equivalent rates of remission and toxicity induced by both treatment regimens, the decision of which treatment to initiate (assuming the patient has no contraindications to either option) is likely strongly influenced by judgments related to the impact of specific adverse events.
Finally, the promise of combining targeted therapies with immunotherapies may provide a mechanism for more durable remissions, given the inevitable development of resistance to current small molecule inhibitors.
Its role in symptom remission is less clear, given the contradictory findings of the two studies with remission data in this review.
Given the differences in major molecular remission (see Table 2) between nilotinib and imatinib in updated ENESTnd data, it will be interesting to evaluate overall survival in those patients which achieved a major molecular remission.
However, given the high rate of tic remission before the typical onset of OCD or OCD-like behavior [ 6] and the high rate of co-occurrence with ADHD, one recommendation of the DSM-5 working group has to be questioned.
